The news of Piper Sandler maintaining an Overweight rating on Alkermes and raising the price target from $35 to $37 is positive for the company. This indicates that the analyst has a positive outlook on the stock and expects it to outperform the market. This could lead to increased investor interest and a potential short-term increase in the stock price.